They demonstrate that LL-37 treatment does not protect against influenza infection by promoting sustained inflammation, but suggest the possibility that cathelicidins may be protective by inhibiting excessive inflammation, or may have a direct anti-viral effect on influenza virus. This evidence concerns the gene CAMP and influenza.